Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.


TSX:TH - Post by User

Comment by SPCEO1on Apr 23, 2021 10:18am
113 Views
Post# 33054577

RE:Short volume is declining

RE:Short volume is declining Don't get too excited about Creative Financial Designs buying more as I am almost certain that purported buying is actually shares a rep there already has held for years andthat they just now started reporting. I don't expect additional buying of any consequence from this firm/rep or for other reps there to start buying.

And the short data Ilook at on Bloomberg also indicates there is almost no short interest in TH. It is even being ignord by the shorts!!!!

scarlet1967 wrote: Also Creative Financial Design Inc. bought about 100k shares..

 

 

 

Market Date

Short Volume

Total Volume

(MM Shares)

Short Volume Ratio

2021-04-22

7,177

0.09

7.98

2021-04-21

13,114

0.08

17.14

2021-04-20

23,898

0.10

24.76

2021-04-19

26,188

0.15

17.71

2021-04-16

5,571

0.12

4.47

2021-04-15

74,190

0.35

21.46

2021-04-14

58,299

0.39

14.79

2021-04-13

111,274

0.47

23.46

2021-04-12

98,186

0.28

35.23

2021-04-09

44,579

0.12

36.48

 

2021-04-19

13F

Creative Financial Designs Inc /adv

 

 

99,258

 

 

 

https://fintel.io/sob/us/thtx

 

 




<< Previous
Bullboard Posts
Next >>